Screening Strategies in Drug Discovery – News and Features

Avalon will use its AvalonRx® platform to discover active compounds in screens against selected targets and target pathways.

Clontech was granted a worldwide exclusive license to sell its Ready-To-Glow™ Secreted Metridia Luciferase Systems.

The NIH Chemical Genomics Center reports that a screening approach can profile compounds in large chemical libraries more accurately than standard methods.

The latest version of GeneGo’s data mining platform MetaCore 4.0 will be integrated with the MDL® suite of databases

Growing membership will help 'RNAi Global' accelerate biomedical discovery using genome-wide siRNA screening.

The Opera will further enhance the capabilities of Eskitis in the area of high content cell biology.

NervianoMS will use services of ChemDiv for building and enriching its portfolio of proprietary discovery chemical libraries.

60 customers shared their experiences with high content screening and analysis.

The goal of the collaboration is the identification of molecules, which bind to a certain illness-relevant target structure provided by Solvay.

Wyeth taps power of Caliper's LabChip 3000 technology via NovaScreen's high-throughput screening services.